---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-003772"
form_type: "8-K"
ticker: "KOD"
cik: "0001468748"
company_name: "Kodiak Sciences Inc."
filed_at: "2021-11-09T23:59:59+00:00"
generated_at: "2026-06-28T10:36:49.626362+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Kodiak Q3 net loss $67.5M ($1.30/shr); cash $799M; pipeline on track for 2022 readouts

## Summary
- Net loss widened to $67.5M ($1.30/shr) from $36.1M ($0.80/shr) in Q3 2020.
- R&D expenses rose to $56.0M (vs $29.3M) on KSI-301 trial and manufacturing costs.
- Cash and equivalents $799.2M; no revenue reported.
- DAZZLE (wet AMD) topline data expected Q1 2022; BEACON (RVO) mid-2022.
- GLEAM/GLIMMER (DME) enrollment target Q1 2022; DAYLIGHT (wet AMD) enrollment 1H 2022.

## SEC filing metadata
- accession: 0000950170-21-003772
- form_type: 8-K
- ticker: KOD
- cik: 0001468748
- company_name: Kodiak Sciences Inc.
- filed_at: 2021-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468748/000095017021003772/0000950170-21-003772-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468748/000095017021003772/kod-20211109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-003772
- JSON: https://secwatch.observer/filing/0000950170-21-003772.json
- Plain text: https://secwatch.observer/filing/0000950170-21-003772.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.